Abstract
THE Mycobacterium bovis strain BCG shares antigenic components with several neoplasms, including human malignant melanoma1–5. Other species of bacteria also have antigenic similarities with a guinea pig hepatoma6. Antibodies to mycobacteria and other bacterial antigens are universally present in sera from normal humans7,8. Since there is a broad range of shared or cross-reactive antigens among mycobacteria and unrelated microorganisms9, it is conceivable that an immune response by normal humans to mycobacteria has been induced by exposure to taxonomically unrelated microorganisms ubiquitous in the environment. Cytotoxic reactions by lymphoid cells from normal animals and humans to many kinds of tumour cells have been reported10–15. Antibodies in sera from patients with various neoplasms have often been observed that react with antigens derived from their own tumours or from those of the same histological type16–18.Humoral responses to tumour-associated antigens have also been noted in sera from normal humans, gibbons and mice19–21. We have investigated whether sera from normal, tumour-free humans contain antibodies which can react with melanoma-associated as well as with BCG antigens. If this were the case, perhaps immunological reactions by normal humans to certain tumours are widespread and reflect previous sensitisation by microorganisms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Borsos, T., and Rapp, H. J., J. natn. Cancer Inst., 51, 1085–1086 (1973).
Bucana, C., and Hanna, M. G., Jr, J. natn. Cancer Inst., 53, 1313–1323 (1974).
Minden, P., McClatchy, J. K., Wainberg, M., and Weiss, D. W., J. natn. Cancer Inst., 53, 1325–1331 (1974).
Minden, P., Sharpton, T. R., and McClatchy, J. K., J. Immun., 116, 1407–1414 (1976).
Lewis, M. G., et al., in The Present Status of BCG in Cancer Immunotherapy (edit. by Lamoureux, E. G., Portelance, V., and Turcotte, R.), (Grune and Stratton, New York, 1976).
Minden, P., Sharpton, T. R., and McClatchy, J. K., Cancer Res., 36, 1680–1685 (1976).
Bardana, E. J., McClatchy, J. K., Farr, R. S., and Minden, P., Clin., exp. Immun., 13, 65–77 (1973).
Minden, P., and Farr, R. S., Chest, 68, 749–750 (1975).
Minden, P., McClatchy, J. K., Cooper, R., Bardana, E. J., and Farr, R. S. Science, 176, 57–58 (1972).
Blair, P. B., Lane, M. A., and Yagi, M. J., J. Immun., 112, 693–705 (1974).
Herberman, R. B., Nunn, M. E., Holden, H. T., and Lavrin, D. H., Int. J. Cancer, 16, 216–229 (1975).
Kiesling, R., Klein, E., and Wigzell, H., Eur. J. Immun., 5, 112–121 (1975).
Tagasugi, M., Mickey, M. R., and Terasaki, P. I., Cancer Res., 33, 2898–2902 (1973).
de Vries, J. E., Meyering, M., van Dongen, A., and Rumke, P., Int. J. Cancer, 15, 391–400 (1975).
Canevari, S., Fossati, G., and Della Porta, G., J. natn. Cancer Inst., 56, 705–709 (1976).
Hellström, I., Hellström, K. E., Pierce, G. E., and Yang, J. P. S., Nature, 220, 1352–1354 (1968).
Lewis, M. G., Med. Clinics of North America, 56, 481–499 (1972).
Bodurtha, A. J., Chee, D. O., Laucius, J. F., Mastrangelo, M. J., and Prehn, R. T., Cancer Res., 35, 189–193 (1975).
Bias, W. B., Santos, G. W., Burke, P. J., Mullins, G. M., and Humphrey, R. L., Science, 178, 304–306 (1972).
Aoki, T., et al., Science, 19, 1180–1183 (1976).
Hanna, M. G., Jr, Ihle, J. N., Batzing, B. L., Tennant, R. W., and Schenley, C. K., Cancer Res., 35, 164–171 (1975).
Minden, P., Farr, R. S., and Trembath, J., Immunochemistry, 12, 477–479 (1975).
Dixon, F. J., The Harvey Lectures, 58, 21 (Academic, New York, 1963).
Lewis, M. G., Phillips, T. M., Cook, K. B., and Blake, J., Nature, 232, 52–53 (1971).
Rowley, D. A., Fitch, F. W., Stuart, F. P., Kohler, H., and Cosenza, H., Science, 181, 1133–1141 (1973).
Lewis, M. G., Hartmann, D., and Jerry, L. M., Proc. N. Y. Acad. Sci., (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MINDEN, P., JARRETT, C., MCCLATCHY, J. et al. Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients. Nature 263, 774–777 (1976). https://doi.org/10.1038/263774a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/263774a0
This article is cited by
-
IgA and IgG antibody detection of mycobacterial antigens in pleural fluid and serum from pleural tuberculous patients
BMC Immunology (2019)
-
Isolation of antibodies to HCG/LH from human sera
Nature (1978)
-
Grenzen und M�glichkeiten der Immuntherapie von Tumoren
Naturwissenschaften (1978)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.